Mirae Asset Global Investments
PMVP icon

Mirae Asset Global Investments’s PMV Pharmaceuticals PMVP Stock Holding History

Mirae Asset Global Investments’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-15,492
Closed -$75.3K – 2269
2024
Q1 		$75.3K Buy
+15,492
New +$28.9K ﹤0.01% 2402
2023
Q4 		– Sell
-16,630
Closed -$102K – 2584
2023
Q3 		$102K Buy
16,630
+103
+0.6% +$708 ﹤0.01% 2454
2023
Q2 		$103K Sell
16,527
-91
-0.5% -$477 ﹤0.01% 2503
2023
Q1 		$79.3K Sell
16,618
-30
-0.2% -$211 ﹤0.01% 2476
2022
Q4 		$145K Buy
16,648
+17
+0.1% +$181 ﹤0.01% 2379
2022
Q3 		$198K Buy
+16,631
New +$240K ﹤0.01% 2339

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Mirae Asset Global Investments's PMVP Position: Q2 2024 in Review

Mirae Asset Global Investments sold out of PMV Pharmaceuticals (PMVP) in Q2 2024, closing a stake of 15,492 shares — an estimated $75.3K sold.

Mirae Asset Global Investments first reported a position in PMVP in Q3 2022 and held it in 6 quarters. The position peaked at $198K in Q3 2022. 93 funds tracked by Wall St. Rank hold PMVP as of Q2 2024.

  • Mirae Asset Global Investments reported no remaining PMV Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Mirae Asset Global Investments sold 15,492 PMV Pharmaceuticals shares in Q2 2024, an estimated $75.3K.
  • Mirae Asset Global Investments first reported a position in PMV Pharmaceuticals in Q3 2022 and held it in 6 quarters.
  • Mirae Asset Global Investments's PMV Pharmaceuticals position peaked at $198K in Q3 2022.
  • 93 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q2 2024.

Based on Mirae Asset Global Investments's 13F filing for Q2 2024, filed 30 Jul 2024.